Lataa...
Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
Several studies have linked circulating cell-free mitochondrial DNA (ccf-mtDNA) to human disease. In particular, reduced ccf-mtDNA levels in the cerebrospinal fluid (CSF) of both Alzheimer’s and Parkinson’s disease (PD) patients have raised the hypothesis that ccf-mtDNA could be used as a biomarker...
Tallennettuna:
| Julkaisussa: | Mol Neurodegener |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7029508/ https://ncbi.nlm.nih.gov/pubmed/32070373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-020-00362-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|